Physician profile
Michael Huang
NPI 1316234222
$8,296.45
in general payments reported to CMS, 2019-2025
13 companies · $77.75 in 2025
The $77.75 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,094 · 2020: $586 · 2021: $65.69 · 2022: $51.32 · 2023: $123 · 2024: $299 · 2025: $77.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $5,487.64 | 2019-2020 | |
| Axogen | $1,924.88 | 2019 | |
| Biohorizons Implant Systems INC. | $405.46 | 2020-2024 | Biohorizons |
| Straumann USA LLC | $147.63 | 2019-2023 | |
| Geistlich Pharma, North America, INC. | $70.29 | 2021-2024 | Geistlich Bio-Gide |
| Zimmer Biomet Holdings, INC. | $49.78 | 2019 | |
| Nobel Biocare USA | $45.80 | 2019 | |
| Biolase, INC. | $44.09 | 2019 | |
| Solventum Corporation | $36.45 | 2025 | 3m Scotchbond, 3m Clinpro, 3m Relyx |
| Depuy Synthes Sales INC. | $27.77 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $21.57 | 2025 | Exparel |
| Dentsply Sirona INC | $19.73 | 2025 | Waveone Gold Conform Fit |
| Merck Sharp & Dohme LLC | $15.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.